Daily20h
FDA Approves Crinecerfont for classic Congenital Adrenal Hyperplasia
The US Food and Drug Administration has approved Crinecerfont for treatment of classic congenital adrenal hyperplasia, ...
Neurocrine's CRENESSITY Gains FDA Approval For Treating Congenital Adrenal Hyperplasia
Neurocrine Biosciences, Inc. (NBIX) said that the U.S. Food and Drug Administration has approved CRENESSITY (crinecerfont) capsules ...
BioSpace6d
FDA Action Alert: Ionis, Lexicon, Bristol Myers Squibb and More
Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...